Comparison of anomaly detection and supervised learning for acute myeloid leukemia blast identification: A proof-of-concept study
Source check: Source checked. Not independent scientific confirmation.
Finding: This retrospective AML flow-cytometry study compares supervised, anomaly-detection and clustering approaches for blast identification and reports markedly different performance by prevalence, including two independent external validation samples. It qualifies narrowly as a clinical diagnostic-validation result.
Technology: Four anomaly detectors, Random Forest and UMAP-HDBSCAN are compared for blast identification using flow-cytometry features.
Publication: Preprint · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.
- AI contribution
- Four anomaly detectors, Random Forest and UMAP-HDBSCAN are compared for blast identification using flow-cytometry features.
- Test and result
- External check uses two independent samples only; results support a small proof-of-concept diagnostic comparison, not general clinical performance or clinical benefit.
- Limitation / still unknown
- External replication and real-world or clinical benefit were not established by the reviewed study; author affiliation is not stated in the reviewed material.
Evidence sources and annotation context
Evidence context (descriptions follow the cited sources; test type is a catalog classification):
Evidence sources: https://export.arxiv.org/api/query?id_list=2610.39447 · https://arxiv.org/pdf/2610.39447
Source checked · editorial details
The source page was checked against this entry. Independent confirmation is not assessed by this label.
Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.
Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..
No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.
Editorial assessment: Impact 2/5 · Validation 2/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.